P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
批准号:
7568858
负责人:
Arthur M. BUCHBERG
金额:
$23.89万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-02-28
关键词:
AffectApoptosisApoptoticAttenuatedBindingBiological AssayBreastBreast CarcinomaCell Cycle ArrestCell Cycle CheckpointCell Cycle RegulationCellsCellular StressCo-ImmunoprecipitationsDNA DamageDNA Microarray ChipElectrophoretic Mobility Shift AssayElementsGene AmplificationGene Expression ProfilingGene TargetingGenesGenetic TranscriptionGenotoxic StressGoalsHumanKnock-outMDM2 geneMalignant NeoplasmsMeasuresMediatingN-terminalNeuroblastomaOvarianPPM1D genePathway interactionsPatternPhosphorylationPhosphotransferasesPlayProtein p53Protein phosphataseReactionReporter GenesResearch PersonnelRoleSignal TransductionStressTP53 geneTestingTimeTranscription CoactivatorTranscriptional ActivationTransfectionTransgenesTumor Cell LineTumor Suppressor ProteinsWestern Blottingabstractingbasechemotherapeutic agentchromatin immunoprecipitationin vivoneoplastic cellnovel therapeutic interventionovarian neoplasmp53 Signaling Pathwayp53-binding proteinprogramspromoterresponsetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
P53-Mediated Gl/M Checkpoint Controls Altered by PPM1D
The p53 tumor suppressor protein is a sequence-specific transcription factor that modulates the response of cells to
genotoxic stress and other forms of cellular stress. PPM1D (formally called Wipl) is transcriptionally-activated in
response to genotoxic stress in a p53-dependent manner. It encodes a protein phosphatase that targets the stress induced
kinase p38MAPK which disrupts the p38MAPK-p53 signalingpathway. This is correlated with alterations in the
pattern of N-terminal phosphorylation on p53 protein. N-terminal phosphorylation is important for p53 protein to
function as a trariscriptional factor. We and others have shown that forced exogenous expression of PPM ID attenuates
the apoptotic response to DNA-damaging agents. Decreasing PPM1D in human tumor cells that constitutively over
express it due to gene amplification enhances the apoptotic response to chemotherapeutic agents. This is correlated with
changes,in the level of expression of the pro-apoptotic Bax gene.The goal of this project is to elucidate the mechanistic
basis and the role that PPM1D plays in modulatingthe transcriptional activity of p53.The hypothesis to be tested is that
disruption of the p38MAPK-p53 signaling pathway by PPM1D affects p53-mediated transcription of responsive genes
involved in cell cycle checkpoint control and/or apoptosis. The Specific Aims are the following: 1) To determine if
PPM ID-mediated disruptionof p38MAPK-p53 signalingalters the interaction between p53 protein and p53-responsive
elements of downstream target genes. 2) To determine if PPMID-mediated disruptionof p38MAPK-p53 signaling
alters the interaction of p53 protein with transcriptional coactivators. 3) To identify and characterize genes whose
expression is altered by PPM ID-mediated disruption of the p38MAPK-p53 signaling pathway.
Lay Abstract: PPM1D is a new player in the p53 network about which we know very little at present. The PPM1D
gene is often amplified in human breast, ovarian and neuroblastoma tumors that harbor a wild type p53 gene. This
project will provide new informationregarding the role that PPM1D plays in the p53 network involved in cell cycle
control and apopotosis and elucidate the mechanistic basis for this action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lab Animal
-
批准号:8302936
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2011
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Lab Animal
-
批准号:8084093
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2010
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Sensitized screen to identify cooperating genes involved in pancreatic cancer
-
批准号:7660263
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7002695
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7163452
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6712794
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6633389
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6124693
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6513550
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6377140
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6101894
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7350950
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7768494
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6268994
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6102571
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6237085
-
项目类别:
-
资助金额:$24.09万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6236418
-
项目类别:
-
资助金额:$26.88万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099261
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:3202730
-
项目类别:
-
资助金额:$17.63万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099260
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: